Thus I agree that 750 USD for 12 weeks is possible
At this moment in time you are both wrong.
What I do know is that an Indian can buy generic Harvoni for $4 a pill or $336 for a 12 week tx
Sorry, but there is no way to sugar coat that.
In the future it will be possible, but right now you would need to be willing to fund (in advance and at a cost of over $1 million USD) an entire production run to get close to this price. You would probably not be getting it from India either due to the 7% royalty paid to Gilead.
Currently in India any price below $1000 USD should be viewed as being too good to be true.
Here is a link to what preports to be community pricing:
And here is some expert commentary about it.
There are many things wrong in this sheet
- First people need to understand Hetero is the only manufacturer and Cipla , Natco and rest all just package it and sell. If you see Hepcivir L Box, it clearly says manufactured by Hetero. So why would Hetero price be higher than Cipla(in your sheet). Cipla and Dr. Reddy’s are premium brand in India over all the others ones in the sheet. Yet they have the lowest prices.
- The absolutely nothing called community pricing. We asked head of sales for Cipla and he confirmed that the only discount that is given is to govt agencies who source meds for BPL(Below Poverty Line) card holders. The packing and barcoding everything reflects that and not a single pill can be distributed outside the authorized BPL channel. These batches are handled directly by manufacturers and not even distributors have access let alone pharmacies.
- Community pricing seems like a scam to sell meds at ridiculous prices.
I am worried, with these practices of selling Schedule H meds without prescription etc something really bad will happen and DCGI will clamp down the whole process.
Here is Dr Andrew Hill's expert commentary on it.
Note that he is not talking current market, but future possibility and gets to an API cost of $193 USD for Harvoni. If this statement was true:
What I do know is that an Indian can buy generic Harvoni for $4 a pill or $336 for a 12 week tx.
Then the current API costs would need to have been at Dr Hill's future forecast price point 2 months ago when the APIs were ordered, prior to manufacture, distribution and sale. Of the final $336 price 57.5% would be API, 7% would be for Gilead and 35.5% ($119 USD) would be all that was available for freight, testing, manufacture, packaging, distribution and reseller margins.
The only people who could meet these unrealistic price expectations will not be selling valid product.
By suggesting these prices are realistic you are doing three things:
- Creating unrealistic patient expectations
- Making it easy for purveyors of fake product
- Making it hard for people providing the real thing as their prices appear too high
Lower prices will come, but at the moment circa $1000 USD is as good as it gets for generic Harvoni and this is only for delivery in India or Bangladesh, not delivered to your door.